2023-503787-17-00招募中1 期
NANOFER-THE-0504: A Trial to Assess the Safety and Tolerability of an Investigational Drug THE-0504 for Patients With Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Pierpaolo Ceci
Scientific
Thena Biotech S.r.l.
研究点 (1)
Loading locations...
相似试验
已完成
不适用
ONO-1110-03 : A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-1110 in Healthy Japanese Adult Male SubjectsjRCT2071240014Ono Pharmaceutical Co.,LTD6
进行中（未招募）
1 期
Safety and efficacy of NNC 0155-0000-0004 in prevention and treatment of bleeds in previously untreated children with Haemophilia AHaemophilia AMedDRA version: 14.1 Level: LLT Classification code 10018937 Term: Haemophilia A System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-001033-16-GRovo Nordisk A/S60
进行中（未招募）
1 期
To Study the Safety and Effectiveness of New LASER Treatment in Glaucoma patientsCTRI/2019/12/022443ALeyeGN Technologies LLC
进行中（未招募）
4 期
To assess safety and effectiveness of Rivaroxaban(Xarelto)in managing coronary and or symptomatic peripheral artery disease in Indian PatientsCTRI/2022/01/039597Bayer Zydus Pharma Pvt Ltd
进行中（未招募）
4 期
Eye drops in Indian Subjects to treat dry eyeCTRI/2022/03/041175Alcon Research Ltd177